Anemia in kidney disease is caused by low erythropoietin and iron problems. Modern treatment uses IV iron and targeted erythropoietin therapy to safely raise hemoglobin to 10-11.5 g/dL, improving energy and reducing heart risks. New oral drugs are changing the game.
read more